BeOne Medicines (ONC) Change in Account Payables (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Change in Account Payables data on file, last reported at -$42.2 million in Q1 2026.

• Quarterly Change in Account Payables fell 33.64% year-over-year to -$42.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.2 million (up 58.64% YoY) and the FY2025 annual result came in at $79.8 million, down 34.29% from the prior year.
• Change in Account Payables retreated to -$42.2 million in Q1 2026 per ONC's latest filing, from $87.2 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $108.0 million in Q4 2024 and bottomed at -$44.1 million in Q2 2024.
• The 5-year median for Change in Account Payables is -$4.3 million (2025), against an average of $10.4 million.
• Peak annual rise in Change in Account Payables reached 1192.5% in 2024, while the deepest fall reached 337.19% in 2024.
• Tracing ONC's Change in Account Payables over 5 years: stood at -$8.6 million in 2022, then fell by 15.51% to -$9.9 million in 2023, then jumped by 1192.5% to $108.0 million in 2024, then retreated by 19.22% to $87.2 million in 2025, then slumped by 148.37% to -$42.2 million in 2026.
• Per Business Quant, the three latest ONC Change in Account Payables figures stand at -$42.2 million (Q1 2026), $87.2 million (Q4 2025), and $28.5 million (Q3 2025).

Peer Comparison